Clinical Trials Directory

Trials / Completed

CompletedNCT04601896

Evaluation of Quality of Life and Its Influencing Factors After VA-ECMO in Refractory Cardiac Arrest Based on SF-36 Score : A Grenoble Cohort Study From 2006 Through 2018

Status
Completed
Phase
Study type
Observational
Enrollment
75 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

If the ExtraCorporeal Membrane Oxygenation (ECMO) improves survival in the management of refractory cardiac arrest (RCA), this technique is still an invasive technique, not devoid of complications and requiring intensive care that can have serious consequences for patients. If the studies so far show an acceptable quality of life post ECMO in refractory cardiac arrest, the study looks about the quality of life of our patients in Grenoble who survived a refractory cardiac arrest between 2006 and 2018 at the hospital university Grenoble Alps and the factors influencing this quality of life.

Conditions

Interventions

TypeNameDescription
OTHERSF36 questionnaire via telephone interviewSF36 questionnaire via telephone interview

Timeline

Start date
2020-10-16
Primary completion
2021-01-15
Completion
2021-04-27
First posted
2020-10-26
Last updated
2021-04-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04601896. Inclusion in this directory is not an endorsement.

Evaluation of Quality of Life and Its Influencing Factors After VA-ECMO in Refractory Cardiac Arrest Based on SF-36 Scor (NCT04601896) · Clinical Trials Directory